What is BLRX's relative strength rating?

BLRX ranks at the 64th percentile over 1 month, 43th percentile over 3 months, 52th percentile over 6 months, 32th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is BLRX in?

BLRX is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is BLRX in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). BLRX benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is BLRX?

BLRX currently shows a 20-day average daily range (ADR%) of 7.0%, a 90-day beta versus the S&P 500 of 0.38. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does BLRX have a seasonal pattern?

TickerStance computes BLRX's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what BLRX has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did BLRX last report earnings?

No SEC EDGAR filings are linked to BLRX in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

BioLineRX Ltd (BLRX) · RS 52 · Neutral

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, BioLineRX Ltd (BLRX) has a 3-month relative strength percentile of 43 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 47. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 7.0%, relative volume 0.63×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month43pctile

6 month52pctile

1 year32pctile

Classic34IBD pctile

LDR23leadership

0 of 5 lenses lit · avg RS pctile 37

✓ADR%7.0%!A/DE!RVOL0.63×!$ Vol$50K

Market backdrop

47.8Neutral

Trend30% weight44.9 Breadth30% weight50.6 Leadership20% weight42.4 Macro20% weight59.0 Full stance breakdown →

§ Seasonality

10y · since 2022

Best monthMay on averageavg +35.04% · 100% win · n 5

Worst monthJan on averageavg -15.89% · 50% win · n 4

BLRX monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	BLRX Jan avg: -15.89% median: -8.72% win: 50% σ: 32.58% n: 4 2022-04-12 → 2026-07-31	BLRX Feb avg: -2.17% median: -5.72% win: 25% σ: 9.42% n: 4 2022-04-12 → 2026-07-31	BLRX Mar avg: 0.71% median: -13.72% win: 25% σ: 32.32% n: 4 2022-04-12 → 2026-07-31	BLRX Apr avg: -1.11% median: 17.23% win: 60% σ: 28.46% n: 5 2022-04-12 → 2026-07-31	BLRX May avg: 35.04% median: 37.45% win: 100% σ: 16.04% n: 5 2022-04-12 → 2026-07-31	BLRX Jun avg: -14.13% median: -17.46% win: 20% σ: 9.40% n: 5 2022-04-12 → 2026-07-31	BLRX Jul avg: 2.99% median: -3.45% win: 40% σ: 20.41% n: 5 2022-04-12 → 2026-07-31	BLRX Aug avg: 1.59% median: 4.43% win: 50% σ: 15.70% n: 4 2022-04-12 → 2026-07-31 (current)	BLRX Sep avg: -13.13% median: -8.70% win: 25% σ: 19.59% n: 4 2022-04-12 → 2026-07-31	BLRX Oct avg: -14.42% median: -13.00% win: 0% σ: 7.46% n: 4 2022-04-12 → 2026-07-31	BLRX Nov avg: -11.93% median: -10.06% win: 25% σ: 12.72% n: 4 2022-04-12 → 2026-07-31	BLRX Dec avg: -14.04% median: -18.24% win: 25% σ: 15.64% n: 4 2022-04-12 → 2026-07-31

Evidence · 1 of 3

Receipts behind the read

0 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

64

3m

43

6m

52

1y

32

LDR

—

StageWeinstein stage analysis

Stage 1 · Basing

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

Fundamentals · BLRX

Does the business back the chart?

No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m
BLRX
43RS 3m · you

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials

PEERS · Pharmaceutical Products

Same industry, closest relative strength

4 peers · by RS6M

ANNXAnnexon, Inc. Common Stock52 BMRNBioMarin Pharmaceuticals Inc52 PRTAProthena Corporation plc Ordinary Shares52 PFEPfizer Inc.52

Public attention · BLRX

Is the crowd watching?

41/ 100 · vs its own 90-day norm▲ 3 vs 7dOverlooked

Weak relative strength and quiet attention. Little to read here either way.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

News

Reference

Company snapshot

SectorHealthcare

IndustryPharmaceutical Products

SIC2834

Floatn/a

Shares out4.4Mshares

Market cap$13.1MNano Cap

FAQ

Frequently asked questions

What is BLRX's relative strength rating?: BLRX ranks at the 64th percentile over 1 month, 43th percentile over 3 months, 52th percentile over 6 months, 32th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is BLRX in?: BLRX is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is BLRX in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). BLRX benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is BLRX?: BLRX currently shows a 20-day average daily range (ADR%) of 7.0%, a 90-day beta versus the S&P 500 of 0.38. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does BLRX have a seasonal pattern?: TickerStance computes BLRX's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what BLRX has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

BioLineRX Ltd (BLRX) — Stance & relative strength

Lenses lit

Market backdrop

§ Seasonality

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

§ Seasonality

BioLineRX Ltd (BLRX) — Stance & relative strength

BLRX is not confirmed as a leader. 43 is not yet a leadership-grade RS read, Market Stance is 47.8

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?